# OptiVol® Care Pathway

> **NCT00847288** · PHASE4 · COMPLETED · sponsor: **Medtronic Cardiac Rhythm and Heart Failure** · enrollment: 1682 (actual)

## Conditions studied

- Heart Failure

## Interventions

- **OTHER:** Monthly Review Arm
- **OTHER:** Quarterly Review Arm

## Key facts

- **NCT ID:** NCT00847288
- **Lead sponsor:** Medtronic Cardiac Rhythm and Heart Failure
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-03
- **Primary completion:** 2011-03
- **Final completion:** 2011-05
- **Target enrollment:** 1682 (ACTUAL)
- **Last updated:** 2013-05-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00847288

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00847288, "OptiVol® Care Pathway". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00847288. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*